Corklin Steinhart, MD, PhD

Linkedin Team icon

VP, Global Medical Affairs

Dr. Corklin (Corky) Steinhart is a trained physician with extensive patient management and leadership experience in public and private health practices. Corky is also a globally accomplished medical affairs executive with a unique experience in building talented medical affairs organizations which support the launch and the life cycle management of innovative specialty medicines.

Prior to joining MindMed, Corky held a number of positions at CAN Community Health of Sarasota, Florida. He was also the Chief Medical Officer of Payer Matrix, a company specializing in providing expensive treatments for a number of diseases at affordable costs. While at Merck, Corky significantly contributed to the successful launch of both the first zoster vaccine (Zostavax) and the first HIV integrase inhibitor (Isentress).

Corky holds both a BS and MS from Bucknell University in Secondary Education, a PhD in Physiology from The Johns Hopkins University School of Hygiene and Public Health, and a MD degree from the University of South Florida College of Medicine in Tampa. Corky is a Fellow of the American College of Physicians and was previously an Assistant Professor of Internal Medicine at the University of Central Florida College of Medicine in Orlando and a Distinguished Professor at the Shanghai Public Health Clinical Center in Shanghai, China.

Carol Vallone

Chair of the Board of Directors, Chair of Compensation Committee, Member of Audit/Finance Committee

Andreas Krebs

Vice Chair of the Board of Directors, Chair of Nomination and Governance Committee, Member of Audit/Finance Committee

David Gryska

Board Director, Chair of Audit Committee

Roger Crystal, MD

Board Director, Member of Nomination & Governance Committee, Member of Compensation Committee

Robert Barrow

Chief Executive Officer and Board Director

Suzanne Bruhn, PhD

Board Director, Member of Nomination & Governance Committee, Member of Compensation Committee

Schond Greenway, MBA

Chief Financial Officer

Miri Halperin Wernli, PhD

Executive President

Daniel Karlin, MD, MA

Chief Medical Officer

Mark Sullivan, JD

Chief Legal Officer and Corporate Secretary

Francois Lilienthal, MD, MBA

Chief Commercial Officer

Carrie Liao, CPA

Chief Accounting Officer

Robert Silva, PhD

VP, Head of Development

Bridget Walton, MS

VP, Global Regulatory Affairs

Maxim Jacobs, CFA

VP, Investor Relations and Corporate Communications

Robert Malenka, MD, PhD

Chairman of the Scientific Advisory Board, Nancy Friend Pritzker Professor in Psychiatry and Behavioral Sciences at Stanford University

Peter Bergethon, MD

Member, Scientific Advisory Board VP, Head of Quantitative & Clinical Technologies, Biogen, Inc.

Robert Dworkin, PhD

Professor of Anesthesiology and Perioperative Medicine, Neurology, and Psychiatry at University of Rochester

Maurizio Fava, MD

Psychiatrist-in-Chief of the Massachusetts General Hospital (MGH)

Carole Abel, MBA

VP, Programs and Portfolio Office (PPO)

Peter Mack, PhD

VP, Pharmaceutical Development

Corklin Steinhart, MD, PhD

VP, Global Medical Affairs

Phong Duong, PharmD

VP, Global Market Access

Maria Oquendo, MD, PhD

Ruth Meltzer Professor and Chairman of Psychiatry at University of Pennsylvania, Psychiatrist-in-Chief at the Hospital of the University of Pennsylvania

Matthias Liechti, MD, PhD

Scientific Collaborator & Advisor

Kim PC Kuypers, PhD

Scientific Collaborator & Advisor

Peter Gasser, MD

Clinical Advisor